2-(2-methoxy-4-(4-methylpiperazin-1-yl)phenylamino)-10-methyl-5H-benzo[d]pyrimido[4,5-f][1,3]diazepin-6(7H)-one

ID: ALA4762595

PubChem CID: 162660252

Max Phase: Preclinical

Molecular Formula: C24H27N7O2

Molecular Weight: 445.53

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)-c1cc(C)ccc1NC(=O)N2

Standard InChI:  InChI=1S/C24H27N7O2/c1-15-4-6-18-17(12-15)22-20(28-24(32)27-18)14-25-23(29-22)26-19-7-5-16(13-21(19)33-3)31-10-8-30(2)9-11-31/h4-7,12-14H,8-11H2,1-3H3,(H,25,26,29)(H2,27,28,32)

Standard InChI Key:  NXCQFZYPAWGNKP-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
   26.7471  -14.2141    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.7460  -15.0337    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.4541  -15.4426    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.4523  -13.8053    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1639  -15.0346    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1609  -14.2105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8059  -13.6886    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.6137  -13.8637    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.9752  -14.6073    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.6230  -15.3576    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8178  -15.5453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.5793  -16.3349    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.1450  -16.9375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.9523  -16.7452    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.1870  -15.9558    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.1186  -13.2211    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   26.0380  -15.4417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.0373  -16.2589    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.3292  -16.6654    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.3282  -17.4818    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0361  -17.8918    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7465  -17.4794    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7440  -16.6643    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.6222  -16.2555    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.9138  -16.6628    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0366  -18.7090    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.3264  -19.1147    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.3249  -19.9283    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0310  -20.3404    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.7403  -19.9326    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7435  -19.1128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0284  -21.1576    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.9101  -17.7202    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  5  2  0
  6  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  5 11  1  0
  7  8  1  0
  8  9  1  0
 10  9  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
  8 16  2  0
  2 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 19 24  1  0
 24 25  1  0
 21 26  1  0
 26 27  1  0
 26 31  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 29 32  1  0
 13 33  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4762595

    ---

Associated Targets(Human)

TNK2 Tclin Tyrosine kinase non-receptor protein 2 (2836 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

BaF3 (4657 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 445.53Molecular Weight (Monoisotopic): 445.2226AlogP: 3.91#Rotatable Bonds: 4
Polar Surface Area: 94.65Molecular Species: NEUTRALHBA: 7HBD: 3
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 12.78CX Basic pKa: 7.84CX LogP: 3.68CX LogD: 3.11
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.56Np Likeness Score: -1.22

References

1. Li Z,Powell CE,Groendyke BJ,Gero TW,Feru F,Feutrill J,Chen B,Li B,Szabo H,Gray NS,Scott DA.  (2020)  Discovery of a series of benzopyrimidodiazepinone TNK2 inhibitors via scaffold morphing.,  30  (19): [PMID:32739400] [10.1016/j.bmcl.2020.127456]

Source